RUSODX Ruxolitinib 15mg

Price range: USD 2,840,000.00 through USD 3,550,000.00

Sold 1,600+
Special Offer

Offline Hong Kong pharmacy with 100% genuine product guarantee

Key Highlights

• (MF) • (PV) , , • 12 (aGVHD) • (cGVHD) 12 , RUSODX

Service Promise

Direct from JapanLicensed PharmacyPharmacist CheckedEditable in Admin

Specifications

Specification
5mg*56 15mg*56

Product Info

English Name
Ruxolitinib 15mg
Chinese Name
RUSODX
Generic Name
RUSODX

Specifications

Specification
5mg*56 15mg*56

Full Details

Indications

• (MF) • (PV) , , • 12 (aGVHD) • (cGVHD) 12 , RUSODX

How It Works

12.1 How It Works Janus (JAK) , JAK1 JAK2, , JAK STAT , STAT , JAK

Pharmacology

12 12.1 How It Works Janus (JAK) , JAK1 JAK2, , JAK STAT , STAT , JAK 12.2 OPZELURA , OPZELURA QT

Dosage

• RUSODX • , RUSODX • RUSODX • RUSODX • RUSODX, RUSODX • RUSODX • RUSODX, 2 • RUSODX, • RUSODX , RUSODX

Drug Interactions

7. OPZELURA P450 3A4 (CYP3A4) CYP3A4 , CYP3A4 [ (12.3)] CYP3A4 OPZELURA CYP3A4 , , OPZELURA [ (12.3)]

Adverse Reactions

o RUSODX , RUSODX RUSODX RUSODX , • • • • • o RUSODX , , • • • • • • • o RUSODX RUSODX , RUSODX , o RUSODX , RUSODX 8 12 o JAK RUSODX , , • , • • • • • • • • o JAK ,DVT ,PE , RUSODX , , • • • o JAK , RUSODX MF PV • • • • • • RUSODX aGVHD • • • • • RUSODX cGVHD • • • , RUSODX ,

Package Insert

Ingredients

11 Janus , (R)-3-(4-(7H- [2,3-d] -4- )-1H- -1- )-3- , 404.36 g/mol OPZELURA , OPZELURA 15 19.8 , 350 SE 200 20

Indications

• (MF) • (PV) , , • 12 (aGVHD) • (cGVHD) 12 , RUSODX

Dosage

• RUSODX • , RUSODX • RUSODX • RUSODX • RUSODX, RUSODX • RUSODX • RUSODX, 2 • RUSODX, • RUSODX , RUSODX

Adverse Reactions

o RUSODX , RUSODX RUSODX RUSODX , • • • • • o RUSODX , , • • • • • • • o RUSODX RUSODX , RUSODX , o RUSODX , RUSODX 8 12 o JAK RUSODX , , • , • • • • • • • • o JAK ,DVT ,PE , RUSODX , , • • • o JAK , RUSODX MF PV • • • • • • RUSODX aGVHD • • • • • RUSODX cGVHD • • • , RUSODX ,

Use in Pregnancy and Lactation

8.1 , OPZELURA 1-855-463-3463 www.opzelura.pregnancy.incyte.com , , ,

Drug Interactions

7. OPZELURA P450 3A4 (CYP3A4) CYP3A4 , CYP3A4 [ (12.3)] CYP3A4 OPZELURA CYP3A4 , , OPZELURA [ (12.3)]

Clinical Pharmacology

12 12.1 How It Works Janus (JAK) , JAK1 JAK2, , JAK STAT , STAT , JAK 12.2 OPZELURA , OPZELURA QT

Clinical Studies

14 14.1 12 TRuE-AD1 TRuE-AD2,NCT03745638 NCT03745651 1249 12 , BID , 8 20% 12 17 ,9% 65 62%,70% ,23% ,4% ,3% (BSA) 3% 20%, (IGA) 2 3 , 0 4 , BSA 9.8%,39% ,25% IGA 2

Product Reviews (0)

Filter: All Reviews
5.0★★★★★
0 customer reviews0 verified purchases
No reviews yet for this product.

Description

Indications

• (MF) • (PV) , , • 12 (aGVHD) • (cGVHD) 12 , RUSODX

How It Works

12.1 How It Works Janus (JAK) , JAK1 JAK2, , JAK STAT , STAT , JAK

Pharmacology

12 12.1 How It Works Janus (JAK) , JAK1 JAK2, , JAK STAT , STAT , JAK 12.2 OPZELURA , OPZELURA QT

Dosage

• RUSODX • , RUSODX • RUSODX • RUSODX • RUSODX, RUSODX • RUSODX • RUSODX, 2 • RUSODX, • RUSODX , RUSODX

Drug Interactions

7. OPZELURA P450 3A4 (CYP3A4) CYP3A4 , CYP3A4 [ (12.3)] CYP3A4 OPZELURA CYP3A4 , , OPZELURA [ (12.3)]

Adverse Reactions

o RUSODX , RUSODX RUSODX RUSODX , • • • • • o RUSODX , , • • • • • • • o RUSODX RUSODX , RUSODX , o RUSODX , RUSODX 8 12 o JAK RUSODX , , • , • • • • • • • • o JAK ,DVT ,PE , RUSODX , , • • • o JAK , RUSODX MF PV • • • • • • RUSODX aGVHD • • • • • RUSODX cGVHD • • • , RUSODX ,

Additional information

Specification

5mg*56片, 15mg*56片